RVNC : Revance Therapeutics stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-02-06 |
|---|---|---|---|---|
| 2025 | $3.94 | $3.64 | $4.35 | 7.81% |
| 2026 | $5.14 | $4.49 | $5.74 | 40.9% |
| 2027 | $6.48 | $5.86 | $7.02 | 77.49% |
| 2028 | $7.5 | $7.09 | $7.98 | 105.39% |
| 2029 | $8.67 | $8.11 | $8.98 | 137.5% |
| 2030 | $9.11 | $9.01 | $9.2 | 149.59% |
| 2031 | $9.25 | $9.21 | $9.28 | 153.47% |
| 2032 | $9.29 | $9.28 | $9.29 | 154.41% |
| 2033 | $8.9 | $8.02 | $9.29 | 143.7% |
| 2034 | $7.98 | $7.89 | $8.07 | 118.5% |
| 2035 | $8.04 | $8.03 | $8.05 | 120.31% |
The 1 Wall Street analysts offering Revance Therapeutics stock forecast in the last 6 months have average price target of
$3.0 with a high forecast of $3.0 and a low forecast of $3.0.
The average Revance Therapeutics stock forecast represents a -17.81%
decrease from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast for 2025, 8 predictions are offered for each month of 2025 with average Revance Therapeutics stock
forecast of $3.94, a high forecast of $4.35, and a low forecast of $3.64.
The average Revance Therapeutics stock forecast 2025 represents a 7.81%
increase from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Revance Therapeutics stock
forecast of $5.14, a high forecast of $5.74, and a low forecast of $4.49.
The average Revance Therapeutics stock forecast 2026 represents a 40.9%
increase from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Revance Therapeutics stock
forecast of $7.5, a high forecast of $7.98, and a low forecast of $7.09.
The average Revance Therapeutics stock forecast 2028 represents a 105.39%
increase from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Revance Therapeutics stock
forecast of $9.11, a high forecast of $9.2, and a low forecast of $9.01.
The average Revance Therapeutics stock forecast 2030 represents a 149.59%
increase from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast 2031, 12 predictions are offered for each month of 2031 with average Revance Therapeutics stock
forecast of $9.25, a high forecast of $9.28, and a low forecast of $9.21.
The average Revance Therapeutics stock forecast 2031 represents a 153.47%
increase from the last price of $3.65000009536743.
For Revance Therapeutics stock forecast for 2035 (10 year), 4 predictions are offered for each month of 2035 with average Revance Therapeutics stock
forecast of $8.04, a high forecast of $8.05, and a low forecast of $8.03.
The average Revance Therapeutics stock forecast 2035 represents a 120.31%
increase from the last price of $3.65000009536743.
Please, see more forecasts below.
RVNC : Revance Therapeutics stock forecast by Wall Street Analysts
The average Revance Therapeutics stock forecast from last 6 month is $3.0, and this show a -57.14% decrease in average from the prior price target of the each prediction. Also, this average forecast of $3.0 represents a -67.11% decrease from the past average forecast of $9.12, 6 months ago from 6 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-01-17 | Needham | Hold | ||
| 2024-12-23 | Barclays | $7.00 | $3.0000 | Equal-Weight |
| 2024-12-10 | Mizuho | $6.6600 | $3.10 | Neutral |
| 2024-11-08 | Needham | Hold | ||
| 2024-11-08 | HC Wainwright & Co. | $6.6000 | $6.60 | Neutral |
| 2024-10-28 | Needham | Hold | ||
| 2024-09-13 | Barclays | $10.00 | $7.0000 | Equal-Weight |
| 2024-08-13 | Needham | Hold | ||
| 2024-08-12 | Guggenheim | Neutral | ||
| 2024-08-12 | William Blair | Market Perform | ||
| 2024-08-09 | Piper Sandler | $11.00 | $6 | Overweight |
| 2024-08-09 | Stifel | $24.0000 | $20 | Buy |
| 2024-08-09 | Needham | $12.00 | $12 | Buy |
Revance Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-02-07 | $3.58 | -1.84% |
| 2025-02-10 | $3.54 | -1.16% |
| 2025-02-11 | $3.55 | 0.19% |
| 2025-02-12 | $3.56 | 0.37% |
| 2025-02-13 | $3.57 | 0.22% |
RVNC : Long term Revance Therapeutics stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 May. is $3.64 , for 2026 Apr. is $4.89 , for 2029 Apr. is $8.52 , for 2030 Apr. is $9.07 , for 2034 Apr. is $7.89 , and for 2035 Apr. is $8.03.
RVNC : Revance Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 May. | $3.64 | -0.30% |
| 2025 Jun. | $3.67 | 0.97% |
| 2025 Jul. | $3.74 | 1.91% |
| 2025 Aug. | $3.84 | 2.56% |
| 2025 Sep. | $3.95 | 2.91% |
| 2025 Oct. | $4.08 | 3.14% |
| 2025 Nov. | $4.21 | 3.23% |
| 2025 Dec. | $4.35 | 3.27% |
RVNC : Revance Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $4.49 | 3.27% |
| 2026 Feb. | $4.63 | 3.15% |
| 2026 Mar. | $4.76 | 2.92% |
| 2026 Apr. | $4.89 | 2.59% |
| 2026 May. | $5.00 | 2.36% |
| 2026 Jun. | $5.11 | 2.19% |
| 2026 Jul. | $5.22 | 2.03% |
| 2026 Aug. | $5.31 | 1.89% |
| 2026 Sep. | $5.42 | 1.89% |
| 2026 Oct. | $5.52 | 1.90% |
| 2026 Nov. | $5.63 | 1.96% |
| 2026 Dec. | $5.74 | 2.02% |
RVNC : Revance Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $5.86 | 2.04% |
| 2027 Feb. | $5.98 | 2.05% |
| 2027 Mar. | $6.10 | 2.03% |
| 2027 Apr. | $6.22 | 1.98% |
| 2027 May. | $6.34 | 1.90% |
| 2027 Jun. | $6.45 | 1.81% |
| 2027 Jul. | $6.56 | 1.69% |
| 2027 Aug. | $6.67 | 1.59% |
| 2027 Sep. | $6.76 | 1.45% |
| 2027 Oct. | $6.85 | 1.33% |
| 2027 Nov. | $6.94 | 1.21% |
| 2027 Dec. | $7.02 | 1.14% |
RVNC : Revance Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $7.09 | 1.07% |
| 2028 Feb. | $7.16 | 1.01% |
| 2028 Mar. | $7.23 | 0.97% |
| 2028 Apr. | $7.30 | 0.94% |
| 2028 May. | $7.37 | 0.93% |
| 2028 Jun. | $7.44 | 0.94% |
| 2028 Jul. | $7.51 | 0.97% |
| 2028 Aug. | $7.59 | 1.03% |
| 2028 Sep. | $7.67 | 1.10% |
| 2028 Oct. | $7.76 | 1.20% |
| 2028 Nov. | $7.86 | 1.32% |
| 2028 Dec. | $7.98 | 1.48% |
RVNC : Revance Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $8.11 | 1.61% |
| 2029 Feb. | $8.25 | 1.69% |
| 2029 Mar. | $8.39 | 1.68% |
| 2029 Apr. | $8.52 | 1.56% |
| 2029 May. | $8.63 | 1.34% |
| 2029 Jun. | $8.72 | 1.08% |
| 2029 Jul. | $8.80 | 0.84% |
| 2029 Aug. | $8.85 | 0.64% |
| 2029 Sep. | $8.90 | 0.49% |
| 2029 Oct. | $8.93 | 0.39% |
| 2029 Nov. | $8.96 | 0.32% |
| 2029 Dec. | $8.98 | 0.27% |
RVNC : Revance Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $9.01 | 0.25% |
| 2030 Feb. | $9.03 | 0.23% |
| 2030 Mar. | $9.05 | 0.22% |
| 2030 Apr. | $9.07 | 0.22% |
| 2030 May. | $9.09 | 0.21% |
| 2030 Jun. | $9.10 | 0.21% |
| 2030 Jul. | $9.12 | 0.20% |
| 2030 Aug. | $9.14 | 0.19% |
| 2030 Sep. | $9.16 | 0.18% |
| 2030 Oct. | $9.17 | 0.17% |
| 2030 Nov. | $9.19 | 0.16% |
| 2030 Dec. | $9.20 | 0.14% |
RVNC : Revance Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $9.21 | 0.13% |
| 2031 Feb. | $9.22 | 0.11% |
| 2031 Mar. | $9.23 | 0.10% |
| 2031 Apr. | $9.24 | 0.09% |
| 2031 May. | $9.25 | 0.08% |
| 2031 Jun. | $9.25 | 0.07% |
| 2031 Jul. | $9.26 | 0.06% |
| 2031 Aug. | $9.26 | 0.05% |
| 2031 Sep. | $9.27 | 0.04% |
| 2031 Oct. | $9.27 | 0.04% |
| 2031 Nov. | $9.27 | 0.03% |
| 2031 Dec. | $9.28 | 0.03% |
RVNC : Revance Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $9.28 | 0.03% |
| 2032 Feb. | $9.28 | 0.02% |
| 2032 Mar. | $9.28 | 0.02% |
| 2032 Apr. | $9.28 | 0.02% |
| 2032 May. | $9.29 | 0.01% |
| 2032 Jun. | $9.29 | 0.01% |
| 2032 Jul. | $9.29 | 0.01% |
| 2032 Aug. | $9.29 | 0.00% |
| 2032 Sep. | $9.29 | 0.00% |
| 2032 Oct. | $9.29 | 0.00% |
| 2032 Nov. | $9.29 | -0.00% |
| 2032 Dec. | $9.29 | -0.00% |
RVNC : Revance Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $9.29 | -0.01% |
| 2033 Feb. | $9.29 | -0.02% |
| 2033 Mar. | $9.28 | -0.05% |
| 2033 Apr. | $9.27 | -0.11% |
| 2033 May. | $9.25 | -0.27% |
| 2033 Jun. | $9.19 | -0.59% |
| 2033 Jul. | $9.08 | -1.20% |
| 2033 Aug. | $8.90 | -2.05% |
| 2033 Sep. | $8.64 | -2.84% |
| 2033 Oct. | $8.38 | -3.05% |
| 2033 Nov. | $8.17 | -2.52% |
| 2033 Dec. | $8.02 | -1.86% |
RVNC : Revance Therapeutics stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $7.93 | -1.13% |
| 2034 Feb. | $7.91 | -0.24% |
| 2034 Mar. | $7.91 | -0.02% |
| 2034 Apr. | $7.89 | -0.17% |
| 2034 May. | $7.90 | 0.12% |
| 2034 Jun. | $7.93 | 0.37% |
| 2034 Jul. | $7.97 | 0.53% |
| 2034 Aug. | $8.02 | 0.55% |
| 2034 Sep. | $8.05 | 0.40% |
| 2034 Oct. | $8.07 | 0.20% |
| 2034 Nov. | $8.07 | 0.03% |
| 2034 Dec. | $8.06 | -0.08% |
RVNC : Revance Therapeutics stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $8.05 | -0.12% |
| 2035 Feb. | $8.04 | -0.12% |
| 2035 Mar. | $8.04 | -0.08% |
| 2035 Apr. | $8.03 | -0.03% |
Frequently Asked Questions about Revance Therapeutics stock forecast
Is Revance Therapeutics a good long term stock?
From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock cannot be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2025 May. is $3.6392262297951112 From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock can be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2026 Apr. is $4.887600926613602 From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock can be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2029 Apr. is $8.515692598676074 From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock can be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2030 Apr. is $9.066612385029345 From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock can be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2034 Apr. is $7.892072823602079 From Revance Therapeutics stock forecast , Revance Therapeutics (RVNC) stock can be a good investment choice. According to AIPickup, the Revance Therapeutics stock price forecast for 2035 Apr. is $8.034030643866
Is Revance Therapeutics stock overvalued?
Revance Therapeutics (RVNC) stock is expected to go UP . Therefore, AIPickup would say that Revance Therapeutics (RVNC) stock is NOT overvalued.
Will Revance Therapeutics stock price go up?
Yes. The Revance Therapeutics stock price forecast for 2026 Apr. is $4.887600926613602
Is Revance Therapeutics stock a good buy now?
Since closing price on 2025-02-06 is $3.65000009536743 and forecast for 2026 Apr. is $4.89, Revance Therapeutics stock is a good 1 year investment.
14 Days Historical Data for Revance Therapeutics stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| RVNC stock price for 2025-01-17 | $3.68 | $3.66 | $3.60 | $3.70 |
| RVNC stock price for 2025-01-21 | $3.67 | $3.64 | $3.64 | $3.67 |
| RVNC stock price for 2025-01-22 | $3.65 | $3.65 | $3.62 | $3.68 |
| RVNC stock price for 2025-01-23 | $3.67 | $3.65 | $3.64 | $3.69 |
| RVNC stock price for 2025-01-24 | $3.65 | $3.67 | $3.65 | $3.69 |
| RVNC stock price for 2025-01-27 | $3.64 | $3.65 | $3.64 | $3.67 |
| RVNC stock price for 2025-01-28 | $3.65 | $3.64 | $3.64 | $3.66 |
| RVNC stock price for 2025-01-29 | $3.64 | $3.65 | $3.63 | $3.66 |
| RVNC stock price for 2025-01-30 | $3.63 | $3.64 | $3.62 | $3.66 |
| RVNC stock price for 2025-01-31 | $3.63 | $3.64 | $3.62 | $3.65 |
| RVNC stock price for 2025-02-03 | $3.64 | $3.63 | $3.63 | $3.64 |
| RVNC stock price for 2025-02-04 | $3.64 | $3.63 | $3.63 | $3.65 |
| RVNC stock price for 2025-02-05 | $3.65 | $3.65 | $3.65 | $3.66 |
| RVNC stock price for 2025-02-06 | $3.65 | $3.65 | $3.65 | $3.65 |